PMB definition guideline v7.5
This guideline seeks to clarify PMB entitlements of medical scheme beneficiaries within the context of the pandemic, ensuring that there is uniform interpretation amongst all stakeholders. It sets out recommendations for the vaccination, screening, diagnosis, treatment, and care of individuals with suspected, and confirmed COVID-19
Joint Press Statement by the CMS, BHF, HFA & Non-affiliated schemes
The Council for Medical Schemes (CMS), together with industry representative bodies the Board of Healthcare Funders (BHF), the Health Funders Association (HFA) and non-affiliated medical schemes (the Funders Working Group), have come together to support efforts to provide broader health coverage through effective management of
Graduate Internship Programme
The CMS is offering a Graduate Internship Programme for unemployed graduates between the ages of 18 and 35, who are in possession of an appropriate qualification in order to gain work-related experience. The following internship positions are available: Supply Chain Management Intern Human Resources Intern Risk
CMScript: Focus on Substance Use Disorders
How do medical schemes treat substance abuse and what is covered under PMB regulations? The PMB regulations include substance abuse and the use of drugs under the following Diagnostic Treatment Pairs (DTP): DTP Code DTP Description Treatment 182T Abuse or dependence on Psychoactive substance, including alcohol Hospital-based management up to 3 weeks/year 910T Acute
CMScript: Focus on Glaucoma
Glaucoma is a PMB condition, which means that all medical schemes are required by law to pay for the diagnosis, treatment, and care of glaucoma regardless of the member’s benefit option. Treatment and care of Glaucoma is explained in terms of the PMB Regulations. Glaucoma is